Jonty Brown became one of the first people to get an "artificial pancreas" from the NHS - and is now an ultramarathon runner.

Cipla launches Afrezza, an orally inhaled insulin powder for diabetes patients in India. A needle-free alternative to ...

Manufactured by Connecticut-based biopharmaceutical company MannKind Corporation, Afrezza was first launched in the United ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

Meet Athul, a sixth grader from Kerala who bravely manages Type 1 diabetes daily, carrying insulin and a glucometer to school ...

Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...

Cipla has launched Afrezza, an inhaled rapid-acting insulin for adults with diabetes, after CDSCO approval, and plans an ...

The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. The Supreme Court of ...

Fathers exposed to microplastics before conception may be setting their daughters up for metabolic problems later in life.

The global boom in weight-loss drugs has reshaped human medicine, propelled pharmaceutical shares and redrawn expectations ...

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication management for individuals using life-saving medicationHighlights: Expands ...